Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.

Steeves TD, Fox SH.

Prog Brain Res. 2008;172:495-513. doi: 10.1016/S0079-6123(08)00924-2. Review.

PMID:
18772048
2.

[Tourette syndrome. Genetics, neuroanatomy and neurotransmitters].

Debes NM, Skov L, Hjalgrim H.

Ugeskr Laeger. 2008 Aug 25;170(35):2695-700. Review. Danish.

PMID:
18761860
3.

[Tics and Gilles de la Tourette syndrome].

Tijero-Merino B, Gómez-Esteban JC, Zarranz JJ.

Rev Neurol. 2009 Jan 23;48 Suppl 1:S17-20. Review. Spanish.

4.

Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research.

Leckman JF, Cohen DJ.

Psychiatr Dev. 1983 Autumn;1(3):301-16. Review.

PMID:
6324164
5.

Transcranial magnetic stimulation in Gilles de la Tourette syndrome.

Orth M.

J Psychosom Res. 2009 Dec;67(6):591-8. doi: 10.1016/j.jpsychores.2009.07.014. Review.

PMID:
19913663
6.

Gilles de la Tourette syndrome.

Suchowersky O.

Can J Neurol Sci. 1994 Feb;21(1):48-52. Review.

PMID:
8180905
7.

Pathophysiology and treatment of secondary obsessive-compulsive behaviors and tics.

Bhangoo RK.

Semin Clin Neuropsychiatry. 2000 Oct;5(4):250-8. Review.

PMID:
11291021
8.

[Gilles de la tourette syndrome: clinical spectrum and management].

Calderón González R, Calderón Sepúlveda RF.

Rev Neurol. 2003 Apr 1-15;36(7):679-88. Review. Spanish.

9.

Gilles de la Tourette's syndrome.

Faridi K, Suchowersky O.

Can J Neurol Sci. 2003 Mar;30 Suppl 1:S64-71. Review.

PMID:
12691479
10.

Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder.

Koo MS, Kim EJ, Roh D, Kim CH.

Expert Rev Neurother. 2010 Feb;10(2):275-90. doi: 10.1586/ern.09.148. Review.

PMID:
20136383
11.

Tourette's syndrome: a behavioral spectrum disorder.

Comings DE.

Adv Neurol. 1995;65:293-303. Review.

PMID:
7872148
12.

[Neuroimaging techniques in the Gilles de la Tourette syndrome].

Lampreave JL, Bittini A, Mateos F, Manzano S, Domínguez P.

Rev Neurol. 1996 Aug;24(132):921-5. Review. Spanish.

PMID:
8755353
13.

Hypothesis III. Tourette syndrome is only one of several causes of a developmental basal ganglia syndrome.

Palumbo D, Maughan A, Kurlan R.

Arch Neurol. 1997 Apr;54(4):475-83. Review.

PMID:
9109750
14.
15.

[New approach to obsessive-compulsive disorder: dopaminergic theories].

Harsányi A, Csigó K, Demeter G, Németh A.

Psychiatr Hung. 2007;22(4):248-58. Review. Hungarian.

PMID:
18167420
16.

Cholinergic mechanisms in Gilles de la Tourette's syndrome.

Sandyk R.

Int J Neurosci. 1995 Mar;81(1-2):95-100. Review.

PMID:
7775075
17.

[Tourette's syndrome - a review].

Riederer F, Stamenkovic M, Schindler SD, Kasper S.

Nervenarzt. 2002 Sep;73(9):805-19. Review. German.

PMID:
12215871
18.

[Psychobiology of compulsive disease].

Lesch KP.

Fortschr Neurol Psychiatr. 1991 Oct;59(10):404-12. Review. German.

PMID:
1761269
19.
20.

Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive compulsive disorder?

Goodman WK, McDougle CJ, Price LH, Riddle MA, Pauls DL, Leckman JF.

J Clin Psychiatry. 1990 Aug;51 Suppl:36-43; discussion 55-8. Review.

PMID:
2199433

Supplemental Content

Support Center